{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:48:49Z","timestamp":1793782129621,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03346-6","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:20:30Z","timestamp":1743466830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Oral administration of Momordica charantia-derived extracellular vesicles alleviates ulcerative colitis through comprehensive renovation of the intestinal microenvironment"],"prefix":"10.1186","volume":"23","author":[{"given":"Bowen","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-2472","authenticated-orcid":false,"given":"Manli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-6526","authenticated-orcid":false,"given":"Mingzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"3346_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","volume":"166","author":"A Gilliland","year":"2024","unstructured":"Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology. 2024;166:44\u201358.","journal-title":"Gastroenterology"},{"key":"3346_CR2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"3346_CR3","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. Nat Rev Dis Primers. 2020;6.","DOI":"10.1038\/s41572-020-0205-x"},{"key":"3346_CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571\u201384.","journal-title":"Lancet"},{"key":"3346_CR5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122:877\u2013902.","journal-title":"Circ Res"},{"key":"3346_CR6","first-page":"1","volume":"2017","author":"T Tian","year":"2017","unstructured":"Tian T, Wang Z, Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev. 2017;2017:1\u201318.","journal-title":"Oxid Med Cell Longev"},{"key":"3346_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","volume":"3","author":"M Schirmer","year":"2018","unstructured":"Schirmer M, Franzosa EA, Lloyd-Price J, Mciver LJ, Schwager R, Poon TW, Ananthakrishnan AN, Andrews E, Barron G, Lake K, et al. Dynamics of metatranscription in the inflammatory bowel disease gut Microbiome. Nat Microbiol. 2018;3:337\u201346.","journal-title":"Nat Microbiol"},{"key":"3346_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2468-1253(17)30031-6","volume":"2","author":"G Rogler","year":"2017","unstructured":"Rogler G. Resolution of inflammation in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2017;2:521\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3346_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00709-019-01435-6","volume":"257","author":"Y Cui","year":"2019","unstructured":"Cui Y, Gao J, He Y, Jiang L. Plant extracellular vesicles. Protoplasma. 2019;257:3\u201312.","journal-title":"Protoplasma"},{"key":"3346_CR10","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.2147\/IJN.S428647","volume":"18","author":"W He","year":"2023","unstructured":"He W, Zheng S, Zhang H, Gao B, Jin J, Zhang M, He Q. Plant-Derived Vesicle-Like nanoparticles: clinical application exploration and challenges. Int J Nanomed. 2023;18:5671\u201383.","journal-title":"Int J Nanomed"},{"key":"3346_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2022.08.046","volume":"350","author":"Z Fang","year":"2022","unstructured":"Fang Z, Liu K. Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release. 2022;350:389\u2013400.","journal-title":"J Control Release"},{"key":"3346_CR12","doi-asserted-by":"crossref","unstructured":"Cong M, Tan S, Li S, Gao L, Huang L, Zhang H-G, Qiao H. Technology insight: Plant-derived vesicles\u2014How Far from the clinical biotherapeutics and therapeutic drug carriers? Adv Drug Deliver Rev. 2022;182.","DOI":"10.1016\/j.addr.2021.114108"},{"key":"3346_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s40495-016-0045-2","volume":"2","author":"D Kwatra","year":"2016","unstructured":"Kwatra D, Dandawate P, Padhye S, Anant S. Bitter melon as a therapy for diabetes, inflammation, and cancer: a panacea?? Curr Pharmacol Rep. 2016;2:34\u201344.","journal-title":"Curr Pharmacol Rep"},{"key":"3346_CR14","doi-asserted-by":"crossref","unstructured":"Sur S, Ray RB. Diverse roles of bitter melon (<\u2009i\u2009>\u2009Momordica charantia) in prevention of oral cancer. J Cancer Metas Treat. 2021;2021.","DOI":"10.20517\/2394-4722.2020.126"},{"key":"3346_CR15","doi-asserted-by":"crossref","unstructured":"Wang B, Guo X-J, Cai H, Zhu Y-H, Huang L-Y, Wang W, Luo L, Qi S-H. Momordica charantia-derived extracellular vesicles-like nanovesicles inhibited glioma proliferation, migration, and invasion by regulating the PI3K\/AKT signaling pathway. J Funct Foods. 2022;90.","DOI":"10.1016\/j.jff.2022.104968"},{"key":"3346_CR16","doi-asserted-by":"crossref","unstructured":"Cai H, Huang L-Y, Hong R, Song J-X, Guo X-J, Zhou W, Hu Z-L, Wang W, Wang Y-L, Shen J-G et al. Momordica Charantia Exosome-Like nanoparticles exert neuroprotective effects against ischemic brain injury via inhibiting matrix metalloproteinase 9 and activating the AKT\/GSK3\u03b2 signaling pathway. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.908830"},{"key":"3346_CR17","doi-asserted-by":"crossref","unstructured":"Feng T, Wan Y, Dai B, Liu Y. Anticancer activity of bitter Melon-Derived vesicles extract against breast cancer. Cells. 2023;12.","DOI":"10.3390\/cells12060824"},{"key":"3346_CR18","doi-asserted-by":"crossref","unstructured":"Yang M, Luo Q, Chen X, Chen F. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma. J Nanobiotechnol. 2021;19.","DOI":"10.1186\/s12951-021-00995-1"},{"key":"3346_CR19","doi-asserted-by":"crossref","unstructured":"Cui W-W, Ye C, Wang K-X, Yang X, Zhu P-Y, Hu K, Lan T, Huang L-Y, Wang W, Gu B et al. Momordica. charantia-Derived extracellular Vesicles-Like nanovesicles protect cardiomyocytes against radiation injury via attenuating DNA damage and mitochondria dysfunction. Front Cardiovasc Med. 2022;9.","DOI":"10.3389\/fcvm.2022.864188"},{"key":"3346_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, D\u2019angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Bio. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"3346_CR21","doi-asserted-by":"crossref","unstructured":"Mulcahy LA, Pink RC, Carter DRF. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3.","DOI":"10.3402\/jev.v3.24641"},{"key":"3346_CR22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones G-R, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastro Hepat. 2023;20:538\u201353.","journal-title":"Nat Rev Gastro Hepat"},{"key":"3346_CR23","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97:2499\u2013574.","journal-title":"Arch Toxicol"},{"key":"3346_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2013","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Bio. 2013;15:49\u201363.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"3346_CR25","first-page":"2977","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Bba-Mol Cell Res. 2016;1863:2977\u201392.","journal-title":"Bba-Mol Cell Res"},{"key":"3346_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Bio. 2019;20:175\u201393.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"3346_CR27","doi-asserted-by":"crossref","unstructured":"Chen X, Xing X, Lin S, Huang L, He L, Zou Y, Zhang X, Su B, Lu Y, Zheng D. Plant-derived nanovesicles: harnessing nature\u2019s power for tissue protection and repair. J Nanobiotechnol. 2023;21.","DOI":"10.1186\/s12951-023-02193-7"},{"key":"3346_CR28","doi-asserted-by":"crossref","unstructured":"Li X-Y, Meng L, Shen L, Ji H-F. Regulation of gut microbiota by vitamin C, vitamin E and \u03b2-carotene. Food Res Int. 2023;169.","DOI":"10.1016\/j.foodres.2023.112749"},{"key":"3346_CR29","doi-asserted-by":"crossref","first-page":"9974","DOI":"10.1039\/D3FO03327A","volume":"14","author":"R-R Wei","year":"2023","unstructured":"Wei R-R, Lin Q-Y, Adu M, Huang H-L, Yan Z-H, Shao F, Zhong G-Y, Zhang Z-L, Sang Z-P, Cao L, et al. The sources, properties, extraction, biosynthesis, pharmacology, and application of lycopene. Food Funct. 2023;14:9974\u201398.","journal-title":"Food Funct"},{"key":"3346_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/an.114.007955","volume":"7","author":"JL Sherriff","year":"2016","unstructured":"Sherriff JL, O\u2019sullivan T A, Properzi C, Oddo J-L, Adams LA, Choline. Its potential role in nonalcoholic fatty liver disease, and the case for human and bacterial genes. Adv Nutr. 2016;7:5\u201313.","journal-title":"Adv Nutr"},{"key":"3346_CR31","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.3390\/ijms11104149","volume":"11","author":"H Schneider","year":"2010","unstructured":"Schneider H, Braun A, F\u00fcllekrug J, Stremmel W, Ehehalt R. Lipid based therapy for ulcerative Colitis\u2014Modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int J Mol Sci. 2010;11:4149\u201364.","journal-title":"Int J Mol Sci"},{"key":"3346_CR32","doi-asserted-by":"crossref","unstructured":"Chen X, Liu B, Li X, An TT, Zhou Y, Li G, Wu-Smart J, Alvarez S, Naldrett MJ, Eudy J et al. Identification of anti\u2010inflammatory vesicle\u2010like nanoparticles in honey. J Extracell Vesicles. 2021;10.","DOI":"10.1002\/jev2.12069"},{"key":"3346_CR33","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. Lancet. 2017;389:1756\u201370.","journal-title":"Lancet"},{"key":"3346_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41575-023-00766-3","volume":"20","author":"A Horowitz","year":"2023","unstructured":"Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastro Hepat. 2023;20:417\u201332.","journal-title":"Nat Rev Gastro Hepat"},{"key":"3346_CR35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroent. 2017;11:821\u201334.","journal-title":"Expert Rev Gastroent"},{"key":"3346_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP De Souza","year":"2015","unstructured":"De Souza HSP, Fiocchi C. Immunopathogenesis of IBD: current state of the Art. Nat Rev Gastro Hepat. 2015;13:13\u201327.","journal-title":"Nat Rev Gastro Hepat"},{"key":"3346_CR37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao D, Dong M, Dai C, Wu S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;25:1595\u2013602.","journal-title":"Inflamm Bowel Dis"},{"key":"3346_CR38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2018","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, Mciver LJ, et al. Gut Microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2018;4:293\u2013305.","journal-title":"Nat Microbiol"},{"key":"3346_CR39","doi-asserted-by":"crossref","unstructured":"Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence?? IBD treatment targeting the gut Microbiome. Pathogens. 2019;8.","DOI":"10.3390\/pathogens8030126"},{"key":"3346_CR40","doi-asserted-by":"crossref","unstructured":"Wahlstr\u00f6m A, Sayin Sama i, Marschall H-U, B\u00e4ckhed F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab. 2016;24:41\u201350.","DOI":"10.1016\/j.cmet.2016.05.005"},{"key":"3346_CR41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of Tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716\u201324.","journal-title":"Cell Host Microbe"},{"key":"3346_CR42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","volume":"31","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND, Zhao Y-Y, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transpl. 2016;31:737\u201346.","journal-title":"Nephrol Dial Transpl"},{"key":"3346_CR43","doi-asserted-by":"crossref","unstructured":"Lian MQ, Chng WH, Liang J, Yeo HQ, Lee CK, Belaid M, Tollemeto M, Wacker MG, Czarny B, Pastorin G. Plant-derived extracellular vesicles: recent advancements and current challenges on their use for biomedical applications. J Extracell Vesicles. 2022;11.","DOI":"10.1002\/jev2.12283"},{"key":"3346_CR44","doi-asserted-by":"crossref","unstructured":"Feng J, Xiu Q, Huang Y, Troyer Z, Li B, Zheng L. Plant-Derived Vesicle\u2010Like nanoparticles as promising biotherapeutic tools: present and future. Adv Mater. 2023;35.","DOI":"10.1002\/adma.202207826"},{"key":"3346_CR45","doi-asserted-by":"crossref","unstructured":"Xiao Q, Zhao W, Wu C, Wang X, Chen J, Shi X, Sha S, Li J, Liang X, Yang Y et al. Lemon-Derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by Endocytosis\u2010Triggered energy dissipation and energy production reduction. Adv Sci. 2022;9.","DOI":"10.1002\/advs.202105274"},{"key":"3346_CR46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jconrel.2024.01.060","volume":"367","author":"G Yan","year":"2024","unstructured":"Yan G, Xiao Q, Zhao J, Chen H, Xu Y, Tan M, Peng L. Brucea Javanica derived exosome-like nanovesicles deliver MiRNAs for cancer therapy. J Control Release. 2024;367:425\u201340.","journal-title":"J Control Release"},{"key":"3346_CR47","doi-asserted-by":"crossref","unstructured":"Zu M, Xie D, Canup BSB, Chen N, Wang Y, Sun R, Zhang Z, Fu Y, Dai F, Xiao B. \u2018Green\u2019 nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Biomaterials. 2021;279.","DOI":"10.1016\/j.biomaterials.2021.121178"},{"key":"3346_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biomaterials.2016.06.018","volume":"101","author":"M Zhang","year":"2016","unstructured":"Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Han MK, Xiao B, Xu C, Srinivasan S, et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321\u201340.","journal-title":"Biomaterials"},{"key":"3346_CR49","doi-asserted-by":"crossref","unstructured":"Sriwastva MK, Deng ZB, Wang B, Teng Y, Kumar A, Sundaram K, Mu J, Lei C, Dryden GW, Xu F et al. Exosome-like nanoparticles from mulberry bark prevent DSS\u2010induced colitis via the AhR\/COPS8 pathway. Embo Rep. 2022;23.","DOI":"10.15252\/embr.202153365"},{"key":"3346_CR50","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.7150\/thno.73650","volume":"12","author":"C Gao","year":"2022","unstructured":"Gao C, Zhou Y, Chen Z, Li H, Xiao Y, Hao W, Zhu Y, Vong CT, Farag MA, Wang Y, et al. Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis. Theranostics. 2022;12:5596\u2013614.","journal-title":"Theranostics"},{"key":"3346_CR51","doi-asserted-by":"crossref","unstructured":"Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the effects and mechanism of Curcumin in the treatment of inflammatory bowel disease. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.908077"},{"key":"3346_CR52","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41401-020-00561-9","volume":"42","author":"J-Y Dong","year":"2020","unstructured":"Dong J-Y, Xia K-J, Liang W, Liu L-L, Yang F, Fang X-S, Xiong Y-J, Wang L, Zhou Z-J, Li C-Y, et al. Ginsenoside Rb1 alleviates colitis in mice via activation of Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 signaling pathway. Acta Pharmacol Sin. 2020;42:1461\u201371.","journal-title":"Acta Pharmacol Sin"},{"key":"3346_CR53","doi-asserted-by":"crossref","unstructured":"Qiu F-S, Wang J-F, Guo M-Y, Li X-J, Shi C-Y, Wu F, Zhang H-H, Ying H-Z, Yu C-H. Rgl-exomiR-7972, a novel plant Exosomal MicroRNA derived from fresh rehmanniae radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomed Pharmacother. 2023;165.","DOI":"10.1016\/j.biopha.2023.115007"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03346-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03346-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03346-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:20:43Z","timestamp":1743466843000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03346-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03346-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All work performed on animals was performed following the Guidelines for Care and Use of Laboratory Animals of Xi\u2019an Jiaotong University and was approved by the Animal Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}